Skip to main content
. 2017 Mar 17;292(18):7519–7530. doi: 10.1074/jbc.M116.773960

Figure 9.

Figure 9.

Dex treatment does not alter H3K9 acetylation at AREs. ChIP assay with anti-H3K9Ac antibody using Hepa1c1c7 cells treated with DEM and DEM + Dex. The average and S.D. (error bars) of the relative enrichments from triplicate reactions are shown. One-way ANOVA and Tukey's post hoc test were performed. *, p < 0.05; **, p < 0.01; ns, nonsignificant.